Walter Van Dyck

Visiting Professor

KU Leuven

Belgium

Research Interests

Explore related searches

Professors in Belgium

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Walter Van Dyck is a Visiting Professor at KU Leuven, Belgium. His research areas include health technology assessment (HTA), precision medicine, and the economic evaluation of pharmaceutical pricing. Recent publications explore the implementation of EU HTA regulations, stakeholder involvement in health policy, and innovative methods for patient-level effectiveness prediction in oncology. He is particularly focused on improving reimbursement policies and accessibility of high-cost therapies across European markets.

Articles (9)

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (3)

Wim Goettsch

Utrecht University

NETHERLANDS

View details

Peter Mol

Professor Drug Regulatory Science

University Medical Center Groningen

NETHERLANDS

View details

Mathias Boënne

Assistant Professor

Utrecht University

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Walter Van Dyck

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

Navigating the path towards successful implementation of the EU HTA Regulation: key takeaways from the 2023 Spring Convention of the European Access Academy

An Inclusive Civil Society Dialogue for Successful Implementation of the EU HTA Regulation: Call to Action to Ensure Appropriate Involvement of Stakeholders and Collaborators

Does constructive feedback improve idea quality in idea contests? Exploring the role of hierarchy and feedback overlap

Pharmaceutical net price transparency across european markets: Insights from a multi-agent simulation model

Barriers and Opportunities for Implementation of Outcome-Based Spread Payments for High-Cost, One-Shot Curative Therapies

Evaluation of precision medicine assessment reports of the Belgian healthcare payer to inform reimbursement decisions

Shedding Light on Reimbursement Policies of Companion Diagnostics in European Countries

Patient-Level Effectiveness Prediction Modeling for Glioblastoma Using Classification Trees

Nearest Neighbour Propensity Score Matching and Bootstrapping for Estimating Binary Patient Response in Oncology: A Monte Carlo Simulation

Collaborators (3)

Wim Goettsch

Peter Mol

Mathias Boënne

Make your next move.